Current Proteomics
Scope & Guideline
Empowering the Future of Proteomics Science
Introduction
Aims and Scopes
- Proteomic Analysis and Characterization:
The journal emphasizes studies that utilize proteomic techniques to analyze protein expression, modifications, and interactions. This includes quantitative proteomics, mass spectrometry, and protein profiling in various biological contexts. - Computational Proteomics and Bioinformatics:
A significant focus is placed on computational approaches to proteomics, including in silico studies, machine learning applications, and bioinformatics tools that assist in the interpretation of proteomic data and the prediction of protein functions. - Drug Discovery and Therapeutic Applications:
The journal features research that explores the role of proteomics in drug discovery, including the identification of potential biomarkers and therapeutic targets, as well as the evaluation of drug efficacy and mechanisms of action. - Clinical Applications and Disease Mechanisms:
Current Proteomics highlights studies that connect proteomic findings to clinical implications, disease mechanisms, and potential therapeutic strategies, thereby bridging the gap between basic research and clinical practice. - Innovative Methodologies in Proteomics:
The journal encourages submissions that report on novel proteomic techniques, including advancements in mass spectrometry, label-free quantification, and the integration of proteomics with other omics technologies.
Trending and Emerging
- Integration of Omics Technologies:
There is a growing trend towards integrating proteomics with genomics, metabolomics, and transcriptomics. This holistic approach allows for a more comprehensive understanding of biological systems and disease states. - Proteomics in Cancer Research:
The journal shows an increasing focus on the application of proteomics in cancer research, particularly in identifying biomarkers for diagnosis, prognosis, and treatment response, as well as understanding tumor biology. - Immunoinformatics and Vaccine Development:
Emerging studies are focusing on the use of proteomics in immunoinformatics for vaccine development. This includes the design of multi-epitope vaccines and the identification of immunogenic proteins from pathogens. - Personalized Medicine and Precision Proteomics:
There is a noticeable shift towards personalized medicine, with proteomics being leveraged to tailor treatments based on individual protein expression profiles and responses to therapies. - Computational Advancements and Machine Learning:
The application of machine learning and artificial intelligence in analyzing proteomic data is on the rise, offering new tools for data interpretation and predictive modeling within proteomics.
Declining or Waning
- Traditional Proteomic Approaches:
There seems to be a waning interest in traditional proteomic methodologies, such as two-dimensional gel electrophoresis, as researchers increasingly favor more advanced techniques like mass spectrometry-based approaches that offer higher resolution and sensitivity. - Basic Studies without Clinical Relevance:
Research focusing solely on basic proteomic studies without clear clinical applications or implications is becoming less common. The journal appears to prioritize studies that connect proteomic data to disease mechanisms or therapeutic implications. - Limited Scope of Plant Proteomics:
Although plant proteomics has been a significant area of research, recent publications suggest a decline in studies focused exclusively on plant proteins, possibly due to a broader focus on human health and disease-related proteomics.
Similar Journals
MOLECULAR & CELLULAR PROTEOMICS
Unveiling the complexities of molecular biology.MOLECULAR & CELLULAR PROTEOMICS, published by Elsevier, stands as a premier journal in the fields of Biochemistry, Analytical Chemistry, and Molecular Biology, with a distinguished Q1 ranking reflecting its high impact and contribution to the scientific community. Established in 2002, this journal has consistently provided a platform for the latest research in protein science, merging molecular biology with advanced analytical techniques. With impressive Scopus rankings—41st in Biochemistry and 16th in Analytical Chemistry—it caters to an audience of researchers, professionals, and students eager to explore cutting-edge developments in proteomics. Although currently not designated as open access, the journal aims to foster knowledge dissemination through accessible research content. As it continues to evolve until 2024, MOLECULAR & CELLULAR PROTEOMICS is essential for anyone passionately engaged in the ever-expanding field of proteomics.
Current Bioinformatics
Pioneering Research in Bioinformatics and BeyondCurrent Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.
Proteomics Clinical Applications
Elevating Patient Outcomes Through Proteomic AdvancesProteomics Clinical Applications, published by Wiley-VCH Verlag GmbH, is a pivotal journal in the realm of Clinical Biochemistry, with an impressive track record since its inception in 2007, continuing its impactful contributions to 2024. With an ISSN of 1862-8346 and an E-ISSN of 1862-8354, this prestigious journal currently holds a commendable Q2 ranking in Clinical Biochemistry, situated at the 54th percentile among its peers within Scopus rankings. Dedicated to the advancement of proteomics and its applications in clinical settings, Proteomics Clinical Applications serves as a bastion for innovative research, fostering knowledge exchange among scientists, healthcare professionals, and students alike. Through its focus on novel methodologies and translational research, the journal aims to bridge the gap between laboratory findings and clinical practice, significantly impacting patient care and outcomes. Although not open access, its content is accessible through various academic databases, ensuring that vital research reaches its intended audience.
Expert Review of Proteomics
Transforming Proteomics Knowledge into Practical Applications.Expert Review of Proteomics, published by TAYLOR & FRANCIS LTD, is a distinguished journal that focuses on the latest advancements in the field of proteomics, a critical area within biochemistry and molecular biology. With an ISSN of 1478-9450 and E-ISSN 1744-8387, this journal has been pivotal in disseminating high-quality research from its inception in 2004 to its planned convergence in 2024. Its influential position is reflected in its 2023 rankings, placing it in the Q2 category for both Biochemistry and Molecular Biology, alongside respectable Scopus rankings that rank it 118th and 141st in its respective categories. Despite its non-open access structure, Expert Review of Proteomics provides researchers and professionals with a vital platform for critical reviews and insights into proteomic methodologies, thus contributing significantly to the global scientific community. By bridging theoretical research with practical applications, it serves as an essential resource for those dedicated to advancing their knowledge and expertise in this dynamic field.
PROTEIN SCIENCE
Transforming Research into Revolutionary DiscoveriesPROTEIN SCIENCE, published by Wiley, is a premier journal dedicated to the field of biochemistry, molecular biology, and medicine, boasting an impressive impact factor that reflects its influence and importance within the academic community. Established in 1992, the journal has continuously provided a platform for high-quality research, with a current classification in the top quartile (Q1) for its critical contributions to the understanding of protein structure and function, as well as its applications in health and disease. With a Scopus ranking placing it in the 91st percentile among its peers, PROTEIN SCIENCE publishes cutting-edge studies and reviews that are essential for researchers, professionals, and students seeking to advance their knowledge in protein research. Although it does not currently offer open access options, the journal remains dedicated to disseminating vital findings that support the ongoing advancements in molecular biology and biochemistry. Researchers can count on PROTEIN SCIENCE for consistently rigorous peer-reviewed content that fosters meaningful dialog and innovation in the life sciences.
Biochemistry Research International
Advancing biochemistry knowledge for a global audience.Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.
Cell Chemical Biology
Bridging Disciplines to Transform Life Sciences.Cell Chemical Biology, published by Cell Press, stands at the forefront of interdisciplinary research in the realms of biochemistry, molecular biology, and pharmacology. With a robust impact factor evident in its prestigious Q1 quartile rankings across multiple categories including Clinical Biochemistry and Drug Discovery for 2023, this journal serves as a critical platform for disseminating cutting-edge scientific discoveries. As an Open Access publication, it ensures that vital research is accessible to a wide audience, fostering collaborations and driving innovation in the life sciences. Based in the United States, and featuring publications from 2016 to 2024, Cell Chemical Biology invites researchers, professionals, and students alike to contribute to its mission of advancing knowledge through rigorous peer-reviewed articles that address both fundamental and applied aspects of chemical biology.
MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.
JOURNAL OF PROTEOME RESEARCH
Advancing the Frontiers of ProteomicsJOURNAL OF PROTEOME RESEARCH is a premier publication in the field of proteomics, disseminating cutting-edge research and methodologies that drive advancements in biochemistry and molecular biology. Published by the American Chemical Society, this esteemed journal boasts a robust impact, as evidenced by its Q1 rankings in both Biochemistry and miscellaneous Chemistry categories for 2023. With a reputation bolstered by a solid Scopus ranking—#64 out of 408 in General Chemistry and #80 out of 438 in Biochemistry—the journal serves as an essential resource for researchers, professionals, and students aiming to deepen their understanding of protein functions and interactions in biological systems. Although it does not operate under an open-access model, the JOURNAL OF PROTEOME RESEARCH remains a critical platform for scholarly discourse, committed to publishing high-quality, peer-reviewed articles through 2024 and beyond. Scholars are encouraged to engage with the pioneering studies and reviews that shape the future of proteomics.
JOURNAL OF BIOLOGICAL CHEMISTRY
Connecting Research and Innovation in BiochemistryJOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.